175 related articles for article (PubMed ID: 38632516)
1. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
Wu Y; Yang J; Xu G; Chen X; Qu X
BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
[TBL] [Abstract][Full Text] [Related]
2. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
Front Immunol; 2022; 13():994034. PubMed ID: 36225939
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
[TBL] [Abstract][Full Text] [Related]
4. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration.
Du X; Zhang Q; Wang S; Chen X; Wang Y
J Clin Lab Anal; 2022 Feb; 36(2):e24214. PubMed ID: 34961985
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets.
Shao H; Ge M; Zhang J; Zhao T; Zhang S
BMC Cancer; 2022 Mar; 22(1):288. PubMed ID: 35300639
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
Tu J; Wang D; Zheng X; Liu B
Front Immunol; 2023; 14():911368. PubMed ID: 36814925
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
[No Abstract] [Full Text] [Related]
8. Interaction gene set between osteoclasts and regulatory CD4
Li F; Tang H; Luo X; Li X; Luo K; Liu S; Liang J; Liao S; Zhong C; Zhan X; Wei Q; Feng W; Liu Y
Cancer Sci; 2023 Jul; 114(7):3014-3026. PubMed ID: 37150900
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract][Full Text] [Related]
10. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
11. Necrotizing apoptosis-related genes prognosis and treatment effect analysis of osteosarcoma in children.
Chen Y; Wu L; Li Y; Zheng J; Zhong S; Gu S; Chen J
J Gene Med; 2024 Jan; 26(1):e3646. PubMed ID: 38100138
[TBL] [Abstract][Full Text] [Related]
12. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
14. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
[TBL] [Abstract][Full Text] [Related]
15. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis.
Feleke M; Feng W; Rothzerg E; Song D; Wei Q; Kõks S; Wood D; Liu Y; Xu J
Exp Biol Med (Maywood); 2022 Jun; 247(11):921-930. PubMed ID: 35285281
[TBL] [Abstract][Full Text] [Related]
17. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
18. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
19. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]